🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — March 2026 Page 4

Survodutide MASH Phase 2b — March 2026

CanadaChris Fri, Aug 15, 2025 at 9:27 PM 31 replies 1,956 viewsPage 4 of 7
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Aug 18, 2025 at 2:09 PM#16

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

30 3RickReta_CO, PharmHunterJen, TomTeleRx and 27 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Aug 18, 2025 at 11:21 PM#17

Following on from KristenIndy — and this may be the naive question:

How long did you give it before you decided it was working?

31 4tane_welly, Dr.PathRoch, mona_PHX and 28 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Aug 19, 2025 at 8:33 AM#18
TrialNerd_Beth said:
The useful move here is to separate what is established from what is widely repeated.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

Happy to go further on any of that.

32 5MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Aug 19, 2025 at 5:45 PM#19
TrialNerd_Beth said:
The useful move here is to separate what is established from what is widely repeated.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: Aug 19, 2025 at 9:45 PM
33 6lori_vegas, Dr.PulmRoch, maya_sedona and 30 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Aug 20, 2025 at 2:57 AM#20

Moderator note: a couple of off-topic posts removed. Carry on.

Last edited: Aug 20, 2025 at 6:57 AM
5 3PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 2 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register